Valuation (41%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 29.86 | N/A |
| PEG Ratio (TTM) | -2.22 | N/A |
| P/S Ratio (TTM) | 5.82 | N/A |
| P/B Ratio (TTM) | 1.48 | N/A |
| P/FCF Ratio (TTM) | 76.15 | N/A |
| Price to 5YR AVG Earnings Ratio | 16.57 | N/A |
| Price to 5YR AVG FCF Ratio | 15.50 | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.55% | N/A |
| ROE (TTM) | 5.11% | N/A |
| Net Profit Margin (TTM) | 19.49% | N/A |
| ROIC 5YR AVG | 18.01% | N/A |
Growth (67%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -14.49% | 20.07% | 3.43% |
| Revenue | 8.33% | 16.12% | 14.52% |
| Net Income | -14.14% | 27.06% | 7.25% |
| Cash Flow | 651.08% | 35.70% | 7.84% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.08 | N/A |
| Quick Ratio (TTM) | 0.08 | N/A |
| D/E Ratio (TTM) | 0.36 | N/A |
| Interest Coverage (TTM) | -0.83 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | 0.87 | N/A |
| Shares Outstanding Growth 5YR AVG | 4.42% | N/A |